Newsletters published on January 31, 2023
In this activity, Dr. Saad Z. Usmani will focus on outlining practical strategies for implementing new and evolving standards of care into the treatment of transplant-ineligible patients with NDMM.
Newsletters published on August 18, 2022
Join Dr. Sagar Lonial as he reviews recent developments in the treatment of newly diagnosed multiple myeloma (NDMM). Included in this discussion are findings from the DETERMINATION, GRIFFIN, CASSIOPEIA, ALCYON, and COLUMBA trials, among others, that may inform treatment for both transplant-eligible and transplant-ineligible NDMM.

Results 1 - 2 of 2